Page last updated: 2024-12-08
mega 8
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
MEGA 8: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 160091 |
| SCHEMBL ID | 788641 |
| MeSH ID | M0174469 |
Synonyms (25)
| Synonym |
|---|
| n-octanoyl-n-methylglucamine, >=97% |
| 85316-98-9 |
| mega-8 |
| n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]octanamide |
| p3tdb90kln , |
| d-glucitol, 1-deoxy-1-(methyl(1-oxooctyl)amino)- |
| mega 8 |
| 1-deoxy-(n-methyloctanamido)-d-glucitol |
| unii-p3tdb90kln |
| n-(d-glucityl)-n-methyloctanamide |
| n-methyl-n-((2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl)octanamide |
| SCHEMBL788641 |
| n-octanoy-n-methylglucamine |
| HB3972 |
| mfcd00134152 |
| n-octanoyl-n-methyl-d-glucamine |
| AKOS027320572 |
| n-octanoyl-n-methylglucamin |
| n-methyl-n-octanoylglucamine |
| octanoyl n-methylglucamide |
| 1-deoxy-1-[methyl(octanoyl)amino]hexitolato |
| DTXSID501005802 |
| AS-55889 |
| A848357 |
| n-methyl-n-((2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl)octanamide(flakes or chunks) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 41.97
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (41.97) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||